The GlaxoSmithKline-backed immunotherapy developer closed an oversubscribed round that took its total funding to approximately $226m.
Author: Robert Lavine
Shea Ventures cheers on Drinks in $15m round
JF Shea’s corporate venturing unit has invested in online wine retailer Drinks as part of a series B round led by Beverly Pacific.
Alabama Futures Fund aligns with corporates for $25m
The fund has closed with backing from Protective Life Insurance and Hoar Construction and will target seed-stage deals for local startups.
Uberall finds investors for $25m extension
United Inernet reinvested in the location data management platform, which doubled its series B round to $50m in the transaction.
OncoResponse answers questions with $40m series B
Helsinn Investment Fund and Alexandria Venture Investments both invested as OncoResponse looks to advance five immuno-oncology drug candidates.
Benson Hill reaps $60m in series C
GV led Benson Hill Biosystems’ latest round, which increased the total raised by the crop specification technology provider to more than $94m.
Ctrip sets $100m course for Zomato
The online travel booking platform is in talks to invest $100m as part of a $400m round that will value the restaurant listings platform at up to $2bn.
Corporate venturing deal net: 3-7 September 2018
E-commerce firm Alibaba has provided an undisclosed amount of series C1 funding for China-based smartphone recycling service Huishoubao, China Money Network reported today. Huishoubao had previously raised angel funding from Source Code Capital in 2015, series A funding from Chengwei Capital and Citic Capital in 2016 and a similarly undisclosed amount of series A-plus funding… Continue reading Corporate venturing deal net: 3-7 September 2018
Alpha Tau gets $29m in funding exposure
Medison Ventures was among the participants in a round that will fund clinical tests for Alpha Tau’s radiation-based cancer treatment.
PhaseBio attracts $34m in series D round
Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio’s orphan disease drug pipeline.
Allogene tallies up $120m
The Pfizer-backed cancer therapy developer has secured $120m in a convertible note offering led by Perceptive Advisors.
Saudi Aramco scrutinises plans for $1bn fund
The oil and gas provider, which already runs the $500m Saudi Aramco Energy Ventures unit, is reportedly mulling plans for a larger fund.
Meituan Dianping confirms $4.4bn IPO plans
The Tencent-backed local services portal plans to float in Hong Kong in two weeks time and has locked up $1.5bn in investment already.
Sky pays $4m to Reimagine Ventures
Remagine Ventures, a fund formed by ex-corporate venturers Eze Vidra and Kevin Baxpehler, has secured Sky as a limited partner.